Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer
(Q78245367)
scientific article published on 01 August 1999
scientific article published on 01 August 1999
Language:
Current Data About
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer